836 related articles for article (PubMed ID: 22208975)
21. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
22. Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast.
Boland GP; McKeown A; Chan KC; Prasad R; Knox WF; Bundred NJ
Br J Cancer; 2003 Jul; 89(2):277-83. PubMed ID: 12865917
[TBL] [Abstract][Full Text] [Related]
23. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
[TBL] [Abstract][Full Text] [Related]
24. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
25. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
[TBL] [Abstract][Full Text] [Related]
26. Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.
Claus EB; Chu P; Howe CL; Davison TL; Stern DF; Carter D; DiGiovanna MP
Exp Mol Pathol; 2001 Jun; 70(3):303-16. PubMed ID: 11418009
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
[TBL] [Abstract][Full Text] [Related]
28. The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.
Wo JY; Taghian AG; Nguyen PL; Raad RA; Sreedhara M; Bellon JR; Wong JS; Gadd MA; Smith BL; Harris JR
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):188-96. PubMed ID: 20171798
[TBL] [Abstract][Full Text] [Related]
29. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
[TBL] [Abstract][Full Text] [Related]
30. Outcomes and factors impacting local recurrence of ductal carcinoma in situ.
Weng EY; Juillard GJ; Parker RG; Chang HR; Gornbein JA
Cancer; 2000 Apr; 88(7):1643-9. PubMed ID: 10738223
[TBL] [Abstract][Full Text] [Related]
31. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
[TBL] [Abstract][Full Text] [Related]
34. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of low-risk ductal carcinoma in situ in Southeast Asian women treated with breast conservation therapy.
Wong FY; Wang F; Chen JJ; Tan CH; Tan PH
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):998-1003. PubMed ID: 24661651
[TBL] [Abstract][Full Text] [Related]
38. Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I; Livi L; Franceschini D; Saieva C; Meacci F; Marrazzo L; Bendinelli B; Scotti V; De Luca Cardillo C; Nori J; Sanchez L; Orzalesi L; Bonomo P; Greto D; Bucciolini M; Bianchi S; Biti G
Eur J Surg Oncol; 2013 Jun; 39(6):613-8. PubMed ID: 23523088
[TBL] [Abstract][Full Text] [Related]
39. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
[TBL] [Abstract][Full Text] [Related]
40. The use of oncoplastic reduction techniques to reconstruct partial mastectomy defects in women with ductal carcinoma in situ.
Song HM; Styblo TM; Carlson GW; Losken A
Breast J; 2010; 16(2):141-6. PubMed ID: 20102367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]